Rabbit Recombinant Monoclonal NEAS antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 9 publications.
View Alternative Names
NEAS, SPTA2, SPTAN1, Alpha-II spectrin, Fodrin alpha chain
- WB
Unknown
Western blot - Anti-NEAS antibody [EPR3017] (AB75755)
All lanes:
Western blot - Anti-NEAS antibody [EPR3017] (ab75755) at 1/2000 dilution
Lane 1:
TF-1 cell lysate at 10 µg
Lane 2:
SH-SY5Y cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
human brain lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 285 kDa
Observed band size: 150 kDa,285 kDa
false
- WB
Unknown
Western blot - Anti-NEAS antibody [EPR3017] (AB75755)
All lanes:
Western blot - Anti-NEAS antibody [EPR3017] (ab75755) at 1/1000 dilution
Lane 1:
HeLa cell lysate treated with Camptothecin at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
Jurkat treated with Staurosporine at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 285 kDa
Observed band size: 120 kDa,150 kDa,285 kDa,85 kDa
false
- WB
Unknown
Western blot - Anti-NEAS antibody [EPR3017] (AB75755)
Merged signal (red and green). Green -ab75755 observed at 285,150,120 kDa using Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) as secondary antibody.
Red - loading control, ab7291 observed at 52 kDa using Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) as secondary antibody.
ab75755 was shown to react with NEAS in HeLa and parental HAP1 cells. lower signal was observed when treated cells (1 μM Staurosporine for 3h) was used. ab75755 and ab7291 (Mouse anti alpha Tubulin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20,000 dilution respectively. Blots were developed with ab216773 and ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NEAS antibody [EPR3017] (ab75755) at 1/1000 dilution
Lane 1:
Untreated HeLa (Human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HeLa, treated with 1 µM Staurosporine for 3 hours, whole cell lysate at 20 µg
Lane 3:
Untreated parental HAP1 (Wildtype control Human chronic myelogenous leukemia near-haploid cell line), whole cell lysate at 20 µg
Lane 4:
parental HAP1, treated with 1 µM Staurosporine for 3 hours, whole cell lysate at 20 µg
Predicted band size: 285 kDa
false
Related conjugates and formulations (1)
-
Anti-NEAS antibody [EPR3017] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NEAS plays an important role in maintaining cellular homeostasis. It is known to be part of a larger protein complex which assists in transmitting external signals into internal cellular responses. This protein is essential for balancing cell proliferation and apoptosis contributing to normal tissue maintenance. Its activity regulates several transcription factors that influence gene expression which are vital for cellular growth and differentiation.
Pathways
NEAS is involved in the MAPK/ERK signaling and PI3K-Akt pathways. These pathways are critical for cell growth survival and metabolism. NEAS interacts with key proteins such as Raf and MEK in the MAPK/ERK pathway enhancing signal transduction for cell proliferation. It also shows an association with PDK1 a component of the PI3K-Akt pathway which plays a role in cell survival mechanisms helping cells adapt to environmental stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Molecules (Basel, Switzerland) 26: PubMed34684832
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 34:108887 PubMed33761363
2021
Applications
Unspecified application
Species
Unspecified reactive species
Epilepsy research 157:106206 PubMed31585309
2019
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 411:86-104 PubMed31129202
2019
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 124:141-151 PubMed30423475
2018
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 102:1-10 PubMed28237317
2017
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 13:2499-505 PubMed26821268
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 130:301-12 PubMed24661059
2014
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurophysiology 109:429-36 PubMed23100132
2012
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com